Showing results (101-110 of 16,627) with videos related to
Sort By:
Pageof 1,663
Cancer Letters|January 11, 2011
Antibody-based fusion proteins to target death receptors in cancerMarco de Bruyn, Edwin Bremer, Wijnand HelfrichCancer Letters|September 1, 1990
Acute inhibition of DNA synthesis in hamster buccal pouch epithelium exposed to indirect acting carcinogensM Nagabhushan, Y K Ng, R Elias, et al.Cancer Letters|September 10, 2010
Cetuximab-conjugated magneto-fluorescent silica nanoparticles for in vivo colon cancer targeting and imagingYoung-Seok Cho, Tae-Jong Yoon, Eue-Soon Jang, et al.Cancer Letters|July 6, 2010
Combating apoptosis and multidrug resistant cancers by targeting lysosomesLine Groth-Pedersen, Marja JäätteläCancer Letters|November 27, 2010
KSHV genotypes A and C are more frequent in Kaposi sarcoma lesions from Brazilian patients with and without HIV infection, respectivelySuzane Ramos da Silva, Ana Paula Ferraz da Silva, Maura Moscardi Bacchi, et al.Cancer Letters|November 16, 2010
Imatinib treatment in chronic myelogenous leukemia: What have we learned so far?Massimo Breccia, Fabio Efficace, Giuliana AlimenaCancer Letters|November 17, 2010
Trp-P-1, a carcinogenic heterocyclic amine, inhibits lipopolysaccharide-induced maturation and activation of human dendritic cellsJun Ho Jeon, Sun Kyung Kim, Jintaek Im, et al.Cancer Letters|December 21, 2010
Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signalingXin He, Yu Wang, Jinhong Zhu, et al.Cancer Letters|January 4, 2011
Expression and prognostic relevance of the death receptor CD95 (Fas/APO1) in renal cell carcinomasStephan Macher-Goeppinger, Justo Lorenzo Bermejo, Nina Wagener, et al.Cancer Letters|February 23, 2011
Overexpression of CRKII increases migration and invasive potential in oral squamous cell carcinomaShin-Ichi Yamada, Souichi Yanamoto, Goro Kawasaki, et al.Pageof 1,663